Evidence map›Paper›PMID 23831362›Full record

ArticleCytotherapy2013

Mobilization of endogenous stem cell populations enhances fracture healing in a murine femoral fracture model.

Chrisoula A Toupadakis, Jennifer L Granick, Myrrh Sagy, Alice Wong, Ehssan Ghassemi, Dai-Jung Chung, Dori L Borjesson, Clare E Yellowley

Abstract read
In one paragraph

Article in Cytotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. CXCR4 Antagonism to Treat Delayed Fracture Healing.Tissue engineering. Part A · 2019
    Article
  7. VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Trauma and Stem Cells: Biology and Potential Therapeutic Implications.International journal of molecular sciences · 2017
    Review
  14. Review
  15. Stem and progenitor cells: advancing bone tissue engineering.Drug delivery and translational research · 2016
    Review
  16. Review
  17. Article
  18. Review
  19. The convergence of fracture repair and stem cells: interplay of genes, aging, environmental factors and disease.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chrisoula A ToupadakisDepartment of Anatomy, Physiology & Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA 95616, USA.
Jennifer L Granick
Myrrh Sagy
Alice Wong
Ehssan Ghassemi
Dai-Jung Chung
Dori L Borjesson
Clare E Yellowley
University of California, Davis · USUniversity of Minnesota · US

Funding

Rapid mobilization of endogenous progenitor cells for bone healingR21AR061604 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI YELLOWLEY-GENETOS, CLARE E · 2012 to 2013
$371k
NIAMS NIH HHS R21 AR061604NIAMS NIH HHS R21AR061604
6 · The paper itself

Abstract

BACKGROUND

aimsDelivery of bone marrow-derived stem and progenitor cells to the site of injury is an effective strategy to enhance bone healing. An alternate approach is to mobilize endogenous, heterogeneous stem cells that will home to the site of injury. AMD3100 is an antagonist of the chemokine receptor 4 (CXCR4) that rapidly mobilizes stem cell populations into peripheral blood. Our hypothesis was that increasing circulating numbers of stem and progenitor cells using AMD3100 will improve bone fracture healing.

methodsA transverse femoral fracture was induced in C57BL/6 mice, after which they were subcutaneously injected for 3 d with AMD3100 or saline control. Mesenchymal stromal cells, hematopoietic stem and progenitor cells and endothelial progenitor cells in the peripheral blood and bone marrow were evaluated by means of flow cytometry, automated hematology analysis and cell culture 24 h after injection and/or fracture. Healing was assessed up to 84 d after fracture by histomorphometry and micro-computed tomography.

resultsAMD3100 injection resulted in higher numbers of circulating mesenchymal stromal cells, hematopoietic stem cells and endothelial progenitor cells. Micro-computed tomography data demonstrated that the fracture callus was significantly larger compared with the saline controls at day 21 and significantly smaller (remodeled) at day 84. AMD3100-treated mice have a significantly higher bone mineral density than do saline-treated counterparts at day 84.

conclusionsOur data demonstrate that early cell mobilization had significant positive effects on healing throughout the regenerative process. Rapid mobilization of endogenous stem cells could provide an effective alternative strategy to cell transplantation for enhancing tissue regeneration.

Indexed as

AnimalsBenzylaminesBone DensityBone MarrowCell Culture TechniquesCells, CulturedCyclamsDisease Models, AnimalEndothelial CellsFemoral FracturesFracture HealingHematopoietic Stem Cell MobilizationHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHeterocyclic CompoundsMaleBenzylaminesCyclamsHeterocyclic CompoundsplerixaforAMD3100bone regenerationfracture repairmobilizationstem cells

Identifiers

PMID23831362
PMCPMC3735657
OpenAlexW2007073900

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.